Leadership Team

Chris Giordano

Chris Giordano

President and Chief Executive Officer

Christopher Giordano has served as CEO and a director on the Tenax board since July 2021 and also as President of Tenax since October 2021. From early 2018 to 2021,...
Stuart Rich, MD

Stuart Rich, MD

CHIEF MEDICAL OFFICER

Dr. Stuart Rich, joined the Company in 2021 from PHPrecisionMed (PHPM), where he was a co-founder and held the positions of Chief Executive Officer and Director from October 2018 until...
Doug Randall

Doug Randall

Chief Business Officer

Mr. Randall has 33 years of pharmaceutical executive experience. Prior to joining the company, Mr. Randall co-founded Phyxius Pharma, Inc. in 2011 where he served as the Chief Commercial Officer....
Douglas Hay, PHD

Douglas Hay, PHD

EVP Of Regulatory Affairs

Dr. Douglas Hay has over 30 years pharmaceutical regulatory experience. Prior to joining the company Dr. Hay was a co-founder of Phyxius Pharma, Inc. where he served as Vice President...
Gillian Andor

Gillian Andor

Vice President of Clinical Operations

Ms. Andor has over 20 years of experience in Clinical Operations. She served most recently as Interim Head, Clinical Development Operations with Noema Pharma, focused on CNS disorders, where she...

Board of Directors

Gerald Proehl

Gerald Proehl

Chairman

Gerald Proehl has served as a director since April 2014 and Chairman since June 2021. Currently, Mr. Proehl is a Founder, President, CEO and Director of Dermata Therapeutics, Inc, a...
June Almenoff, MD, PHD

June Almenoff, MD, PHD

June Almenoff, MD, PhD joined our Board in February 2021. Dr. Almenoff currently serves as a Board Director and advisor to management of numerous biopharma companies and has over 25...
Michael Davidson, MD

Michael Davidson, MD

Dr. Michael Davidson joined the Board in 2021. Since August 2020, Dr. Davidson has served as the Chief Executive Officer of New Amsterdam Pharma B.V., a clinical stage company focused...
Declan Doogan, MD

Declan Doogan, MD

Dr. Declan Doogan joined the Board in February 2021. He has over 30 years of industry experience in both major pharma and biotech. He was the Senior Vice President and...
Robyn Hunter

Robyn Hunter

Robyn Hunter joined our Board in January 2022. She has served as the Chief Financial Officer of SOTIO Biotech, a clinical stage immune-oncology company, since August 2022. Previously, she worked as...
Chris Giordano

Chris Giordano

President and Chief Executive Officer

Christopher Giordano has served as CEO and a director on the Tenax board since July 2021 and also as President of Tenax since October 2021. From early 2018 to 2021,...
Stuart Rich, MD

Stuart Rich, MD

Chief Medical Officer

Dr. Stuart Rich, joined the Company in 2021 from PHPrecisionMed (PHPM), where he was a co-founder and held the positions of Chief Executive Officer and Director from October 2018 until...

Scientific Advisory Board

Sanjiv Shah, MD

Sanjiv Shah, MD

CHAIRMAN

Dr. Sanjiv Shah is the Stone Endowed Professor of Medicine, Director of Research for the Bluhm Cardiovascular Institute, and Director of the HFpEF Program at Northwestern University Feinberg School of...
Barry Borlaug, MD

Barry Borlaug, MD

Dr. Borlaug is Professor of Medicine and Director, Circulatory Failure Research, Division of Cardiovascular Diseases, and Chair for Research, Division of Circulatory Failure, Department of Cardiovascular Medicine at the Mayo...
Daniel Burkhoff, MD, PHD

Daniel Burkhoff, MD, PHD

Dr. Burkhoff obtained Doctor of Philosophy and Medical degrees from The Johns Hopkins School of Medicine and completed a fellowship in Cardiology at The Johns Hopkins Hospital. Dr. Burkhoff then...
Javed Butler, M.D., M.P.H., M.B.A

Javed Butler, M.D., M.P.H., M.B.A

Javed Butler, M.D., M.P.H., M.B.A., is the President of the Baylor Scott and White Research Institute and Senior Vice President for Baylor Scott and White Health. He is also the...